120 results
Page 5 of 6
8-K
EX-99.1
0qc eotzgq
7 Jan 19
Regulation FD Disclosure
7:30am
8-K
EX-99.1
tyc1hqqe dbsjep
20 Nov 18
Sage Therapeutics Receives Notification of PDUFA Extension
4:06pm
8-K
EX-99.1
irz0tnlde0k8 psr
6 Nov 18
Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
turxnb8 uui
2 Nov 18
Other Events
5:26pm
8-K
EX-99.1
kp6lu4ks
2 Nov 18
Other Events
5:26pm
8-K
EX-99.1
k3eyau1bhsy2un5
7 Aug 18
Results of Operations and Financial Condition
7:30am
8-K
EX-99.1
axpnxl 37x
12 Jun 18
Sage Announces Pivotal Phase 3 Trial Status forSAGE-217 in Major Depressive Disorder and Postpartum
7:30am
8-K
EX-99.1
fumrb7f 4h6zbq2
30 May 18
Sage Therapeutics Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in the Treatment of Postpartum Depression
7:30am
8-K
EX-99.1
mcoi3 hby4bm
3 May 18
Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline
12:00am